Overall rank by patents
#1,789
Across all tracked assignees
USPTO PatentsView assignee record - 227 granted patents across 60 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F41H (ARMOUR; ARMOURED TURRETS; ARMOURED OR ARMED VEHICLES; MEANS OF ATTACK OR DEFENCE, e.g. CAMOUFLAGE, IN GENERAL).
The verdict
Axon holds 227 US patents across 60 technology areas, rank #1,789 of 50,000 tracked assignees.
Axon Enterprise, Inc. has been granted 227 US utility patents between 2017 and 2025, placing Axon Enterprise, Inc. at rank #1,789 across all assignees tracked by PlainPatent. This portfolio spans 60 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.0 claims per patent with primary concentration in F41H (ARMOUR; ARMOURED TURRETS; ARMOURED OR ARMED VEHICLES; MEANS OF ATTACK OR DEFENCE, e.g. CAMOUFLAGE, IN GENERAL). As a US Corporation, Axon Enterprise, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Axon sits between Battelle Energy Alliance, Llc (228 patents, rank #1,785) and Flooring Industies Limited, SARL (227 patents, rank #1,793) - the closest US assignees by grant volume. The composite Innovation Score of 61.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 192 grants, compared with 35 in the 2015–2019 window, a +449% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Axon Enterprise, Inc.'s 17.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 60 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Axon Enterprise, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Battelle Energy Alliance, LLC
228 patents
MICRO MOTION, INC.
228 patents
TACHI-S CO., LTD.
228 patents
Ascensia Diabetes Care Holdings AG
227 patents
BMIC LLC
227 patents
BUSINESS OBJECTS SOFTWARE LTD.
227 patents
EXEDY Corporation
227 patents
FLOORING INDUSTIES LIMITED, SARL
227 patents
Axon Enterprise, Inc.
227 patents
What this shows Axon holds 227 patents at rank #1,789, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,789 in granted patent volume.
Other assignees with the most granted patents in Axon's primary technology class.
Axon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 0.9% |
| 2018 | 11 | 4.8% |
| 2019 | 22 | 9.7% |
| 2020 | 39 | 17.2% |
| 2021 | 29 | 12.8% |
| 2022 | 28 | 12.3% |
| 2023 | 39 | 17.2% |
| 2024 | 32 | 14.1% |
| 2025 | 25 | 11.0% |
Top 15 of 60 technology areas
Overall rank by patents
#1,789
Across all tracked assignees
61.3 out of 100
How to use this portfolio
Axon's 227 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.